4152
J . Org. Chem. 1999, 64, 4152-4158
Syn th esis of 1,3-Oxa zin e Der iva tives by P a lla d iu m -Ca ta lyzed
Cycloa d d ition of Vin yloxeta n es w ith Heter ocu m u len es.
Com p letely Ster eoselective Syn th esis of Bicyclic 1,3-Oxa zin es
Chitchamai Larksarp and Howard Alper*
Department of Chemistry, University of Ottawa, 10 Marie Curie, Ottawa, Ontario, Canada, K1N 6N5
Received March 10, 1999
1,3-Oxazines were prepared by palladium-phosphine-catalyzed cycloaddition reactions of vinyl-
oxetanes with heterocumulenes. 4-Vinyl-1,3-oxazin-2-imines were obtained in fine yields by the
reaction of 2-vinyloxetanes with carbodiimides in THF at rt for 12 h using 1.5 mol % Pd2(dba)3‚
CHCl3 and 3 mol % bidentate phosphine ligands (dppe or dppp). When isocyanates were utilized in
the reaction, moderate to good yields of 4-vinyl-1,3-oxazin-2-ones were achieved within 1-2 h at
rt. Palladium-catalyzed cycloaddition of fused-bicyclic vinyloxetanes with heterocumulenes proceeds
in a highly stereoselective fashion affording only the cis-3-aza-1-oxo-9-vinyl[4.4.0]decane derivatives
in 43-98% yield.
In tr od u ction
erocumulenes, the cycloaddition reaction proceeds with
retention of configuration.5 Several methods have been
described for the preparation of 1,3-oxazines by cycload-
dition of heterocumulenes with oxetanes.6 For example,
Baba and co-workers6a,b employed organotin halide-base
complexes as the catalyst for the addition of isocyanates
to an oxetane to form oxazines. The reaction of oxetane
with carbodiimides in the presence of triethylamine has
been described in a US patent.6c However, relatively high
reaction temperatures (100-200 °C) were needed in most
cases. Larock et al.7 have observed the palladium(0)-
catalyzed nucleophillic ring opening of 2-vinyloxetanes
in the synthesis of homoallyllic alcohols (eq 2). A π-allyl
complex may be a reaction intermediate, in analogy to
the 2-vinyloxiranes/heterocumulenes process.4 Therefore,
2-vinyloxetanes could, in principle, be used for cycload-
dition with heterocumulenes to prepare 4-vinyl-1,3-
oxazines.
The synthesis of 1,3-oxazines has attracted attention
in the past because of their potential as antibiotics,1a-d
antitumor,1e-g analgesics,1h,i and anticonvulsants.1j Sev-
eral methods for the preparations of 1,3-oxazine deriva-
tives have previously been reported,1k,l including the use
of heterocumulenes.2
The cycloaddition reaction of heterocumulenes with
three-membered heterocycles are of value for the forma-
tion of five-membered ring heterocycles.3 We previously
reported the use of isocyanates and carbodiimides as
substrates for cycloaddition reactions with oxiranes (X
) O)4 or aziridines (X ) NR)5 (eq 1) catalyzed by
palladium complexes, thus affording oxazolidine or imi-
dazolidine derivatives, respectively. Also, palladium-
catalyzed reaction of carbodiimides with vinyloxiranes in
the presence of BINAP or TolBINAP affords oxazolidin-
imines in high enantiomeric excess.4
Given the complete regio- and stereoselective nature
of the noted vinyloxirane-heterocumulene reactions, we
Furthermore, when enantiomerically pure aziridines
are used in the palladium-catalyzed reaction with het-
(3) (a) Osaki, S. Chem. Rev. 1972, 72, 457. (b) Gunar, V. I.;
Ovechkina, L. F.; Zavyalov, S. I. Chem. Abstr. 1965, 63, 8346 g. (c)
Pietsch, H.; Clauss, K.; Schmidt, E.; J ensen, H. Chem. Abstr. 1976,
84, 135684f. (d) Fukui, K.; Kitano, T. Kogyo Kagaku Zasshi, 1980, 63,
2062. (e) Hassner, A.; Rasmussen, J . K. J . Am. Chem. Soc. 1975, 97,
1451. (f) Karikomi, M.; Yamazaki, T.; Toda, T. Chem. Lett. 1993, 1965.
(g) Trost, B. M.; Sudhakar, A. R. J . Am. Chem. Soc. 1988, 110, 7933.
(h) Baba, A.; Fujiwara, M.; Matsuda, H. Tetrahedron Lett. 1986, 27,
77. (i) Fujiwara, M.; Baba, A.; Matsuda, H. J . Heterocycl. Chem. 1988,
25, 1351. (j) Baba, A.; Seki, K.; Matsuda, H. J . Heterocycl. Chem. 1990,
27, 1925.
(1) (a) Haneishi, T.; Okazaki, T.; Hata, T.; Tamura, C.; Nomura,
M., Naito, A., Seki, I.; Arai, M. J . Antibiot. 1971, 24, 797. (b) Sasaki,
K.; Kusakabe, Y.; Esumi, S. J . Antibiot. 1972, 25, 151. (c) Kusakabe,
Y.; Nagatsu, J .; Shibuya, M.; Kawaguchi, O.; Hirose, C.; Shirato, S. J .
Antibiot. 1972, 25, 44. (d) Kupchan, S. M.; Komoda, Y.; Court, W. A.;
Thomas, G. J . Smith, R. M. Karim, A.; Gilmore, C. J .; Haltivanger, R.
C.; Bryan, R. F. J . Am. Chem. Soc. 1972, 94, 1354. (e) Wani, M. C.;
Taylor, H. L. Wall, M. E. Chem. Soc., Chem. Commun. 1973, 390. (f)
J ohnson, P. Y.; Silver, R. B. J . Heterocycl. Chem. 1975, 10, 1029. (g)
Renullard, S.; Rebhun, L. I. Havic, G. A.; Kupchan, S. M. Science, 1975,
189, 1002. (h) Urban´ski, T.; Ghrne, D.; Szczerek, I.; Modaski, M. Polish
Patent, 54, 007, 1967. (i) Lesher, G. Y.; Surrey, A. R. J . Am. Chem.
Soc. 1955, 77, 636 (j) Mosher, H. S.; Frankel, M. B.; Gregory, M. J .
Am. Chem. Soc. 1953, 75, 5326. (k) Sainsbury, M. In Comprehensive
Heterocyclic Chemistry; Boulton, A. J ., Mckillop, A., Eds.; Pergamon
Press: Canada, 1984; Vol. 3, Part 2B, p 995. (l) Khumtaveeporn, K.;
Alper, H. J . Org. Chem. 1995, 60, 8142.
(4) (a) Larksarp, C.; Alper, H. J . Am. Chem. Soc. 1997, 119, 3709.
(b) Larksarp, C.; Alper, H. J . Org. Chem. 1998, 63, 6229.
(5) (a) Baeg, J . O.; Bensimon, C.; Alper, H. J . Am. Chem. Soc. 1995,
117, 4700. (b) Baeg, J . O.; Alper, H. J . Org. Chem. 1992, 57, 157.
(6) (a) Baba, A.; Kashiwagi, H.; Matsuda, H. Organometallics 1987,
6, 137. (b) Baba, A.; Shibata, I.; Fujiwara, M.; Matsuda, H. Tetrahedron
Lett. 1985, 26, 5167. (c) Metzger, S. H., J r. US Patent 3, 479, 351, 1969.
(7) (a) Larock, R. C.; Stolz-Dunn, S. K. Tetrahedron Lett. 1989, 30,
3487. (b) Larock, R. C.; Ding, S.; Chi, T. Synlett 1993, 145. (c) Larock,
R. C.; Stolz-Dunn, S. K. Synlett 1990, 341.
(2) (a) Eckstein, Z.; Urban´ski, T. Adv. Heterocycl. Chem. 1963, 2,
311. (b) Eckstein, Z.; Urban´ski, T. Adv. Heterocycl. Chem. 1978, 23, 1.
(c) Kato, T.; Katagiri, N.; Yamamoto, Y. Heterocycles 1980, 14, 133.
10.1021/jo990430b CCC: $18.00 © 1999 American Chemical Society
Published on Web 05/07/1999